Alefacept: Clinical Trials

8 trials of Alefacept, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 terminated. 8 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 48Completed 6, Terminated 2

Follow Alefacept: new trials by email Literature Review of Alefacept trials Research Report on Alefacept

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Pilot Study of Alefacept for the Treatment of Pityriasis Rubra Pilaris
Alefacept - Pityriasis Rubra Pilaris
Phase 4TerminatedJoshua Zeichner12008-12-012018-05-11
Long-Term One Year Use of Alefacept (AmeviveĀ®) in Moderate to Severe Chronic Plaque Type Psoriasis
Alefacept - Psoriasis
Phase 4CompletedWake Forest University152008-05-012018-09-11
Alefacept in Subjects With Chronic Plaque Psoriasis Who Failed to Respond to Anti-TNF Therapy
alefacept - Chronic Plaque Psoriasis
Phase 4TerminatedJohn Murray12008-02-012013-02-22
Study to Evaluate the Safety and Efficacy of Alefacept (Amevive) in Subjects With Moderate to Severe Atopic Dermatitis
Alefacept - Atopic Dermatitis
Phase 4CompletedRush University Medical Center52008-01-012011-03-10
Assess the Efficacy and Safety of Alefacept With Narrow Band Ultraviolet B Phototherapy (nbUVB) vs. Alefacept Alone in Chronic Plaque Psoriasis Subjects
alefacept, Narrow Band UVB Phototherapy - Plaque Psoriasis
Phase 4CompletedAstellas Pharma Inc982007-10-012013-01-08
Study to Evaluate the Immune Response to Pneumococcal Vaccine in Alefacept-treated Adults With Chronic Plaque Psoriasis
alefacept, polyvalent pneumococcal vaccine - Chronic Plaque Psoriasis
Phase 4CompletedAstellas Pharma Inc432007-07-012012-02-02
Community Based Trial for AMEVIVEĀ®
Alefacept - Moderate to Severe Chronic Plaque Psoriasis
Phase 4CompletedAstellas Pharma Inc1142004-07-012014-09-08
Safety and Tolerability of Repeat Courses of IM Alefacept
Alefacept - Chronic Plaque Psoriasis
Phase 4CompletedCharite University, Berlin, Germany202004-02-012008-11-20

Conditions studied

Psoriasis (3)  ·  Skin Diseases (2)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  Dermatitis (1)  ·  Dermatitis, Atopic (1)  ·  Pityriasis Rubra Pilaris (1)

Sponsors

Astellas Pharma Inc (3)  ·  Charite University, Berlin, Germany (1)  ·  John Murray (1)  ·  Joshua Zeichner (1)  ·  Rush University Medical Center (1)  ·  Wake Forest University (1)

Countries

United States (5)  ·  Canada (2)  ·  Germany (1)

Top investigators

John C Murray, MD (1)  ·  Joshua Zeichner, MD (1)  ·  Michael D. Tharp, MD (1)  ·  Michael Gold (1)  ·  Steven Feldman, MD (1)  ·  Wolfram Sterry, Prof. M.D. (1)